Martin Auster

Martin Auster

Analyst-Equity bei
Raymond James Financial, Inc. (Broker)
51 Jahre
Finance
Health Technology
Consumer Services

Profil

Dr. Martin Auster, MD, is a Managing Director at Raymond James Financial, Inc. Previously, Dr. Auster served as chief financial officer at Ventyx biosciences from 2021-2024 and was a research analyst at UBS Securities LLC from 2016-2017 and at Credit Suisse Securities (USA) LLC from 2017-2021.
Prior to that, Dr. Auster held the positions of chief business officer at Ascendis Pharma from 2014- 2016 and VP-business development & strategic finance at United Therapeutics Corp.
from 2009-2014.
Earlier in his career, he served as a senior equity analyst at Truist Securities, Inc., as a senior biotechnology analyst at Wachovia Securities LLC, and as a portfolio manager at GLG Partners, Inc. He completed his undergraduate degree at the University of Michigan and obtained a doctorate from the University of Texas Medical Branch at Galveston.

Aktive Positionen von Martin Auster

UnternehmenPositionBeginn
Analyst-Equity 01.03.2025

Ehemalige bekannte Positionen von Martin Auster

UnternehmenPositionEnde
VENTYX BIOSCIENCES, INC. Finanzdirektor/CFO 30.08.2024
Analyst-Equity 01.05.2021
Analyst-Equity 01.08.2017
ASCENDIS PHARMA A/S Investor Relations Kontakt 31.08.2016
UNITED THERAPEUTICS CORPORATION Corporate Officer/Principal 01.05.2014
Sehen Sie sich die Erfahrung von Martin Auster im Detail an

Ausbildung von Martin Auster

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

79

Beziehungen ersten Grades

12

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen12

Finance

Finance

Health Technology

Finance

Finance

Finance

Consumer Services

Finance

Health Technology

Finance

Health Technology

Consumer Services

  1. Börse
  2. Insiders
  3. Martin Auster